Literature DB >> 18716730

Could intravenous cyclosporin A be an effective therapeutic strategy in pulmonary hemorrhage associated with Henoch-Schönlein purpura? Comment on: Pulmonary hemorrhage associated with Henoch-Schönlein purpura in a child [Clin Rheumatol 27(6):803-805].

Jae Il Shin, Jae Seung Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716730     DOI: 10.1007/s10067-008-0992-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  6 in total

Review 1.  [Effect of cyclosporin A on the reactivity of the pulmonary vascular network in dogs].

Authors:  P Mathieu; R Cartier; M Carrier; L C Pelletier
Journal:  Ann Chir       Date:  1996

2.  In vitro immunoglobulin isotype suppression in immunoglobulin A nephropathy.

Authors:  A C Allen; L Layward; S J Harper; J Feehally
Journal:  Exp Nephrol       Date:  1994 May-Jun

3.  The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura.

Authors:  Tae-Sun Ha
Journal:  Pediatr Nephrol       Date:  2004-12-31       Impact factor: 3.714

4.  Successful use of cyclosporin A in severe Schönlein-Henoch nephritis resistant to both methylprednisolone pulse and azathioprine.

Authors:  Jae Il Shin; Jee Min Park; Jae Seung Lee; Ji Hong Kim; Pyung Kil Kim; Hyeon Joo Jeong
Journal:  Clin Rheumatol       Date:  2006-04-14       Impact factor: 2.980

5.  Effect of cyclosporin A on inflammatory cytokine production by human alveolar macrophages.

Authors:  J E Losa García; F Mateos Rodríguez; A Jiménez López; M J García Salgado; M R Martín de Cabo; J Pérez Losada; J L Pérez Arellano
Journal:  Respir Med       Date:  1998-05       Impact factor: 3.415

6.  Pulmonary hemorrhage associated with Henoch-Schönlein purpura in a child.

Authors:  Rie Matsubayashi; Tadashi Matsubayashi; Naoya Fujita; Takuya Yokota; Yoichiro Ohro; Hideo Enoki
Journal:  Clin Rheumatol       Date:  2008-01-15       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.